Hum Mol Genet 2002 Feb 1;11(3):295-300
Vitale E, Cook S, Sun R, Specchia C, Subramanian K, Rocchi M, Nathanson D, Schwalb M, Devoto M, Rohowsky-Kochan C.
Department of Microbiology and Molecular Genetics, UMDNJ, Newark, NJ, USA, CNR Institute of Cibernetics, Naples, Italy, Department of Neuroscience, UMDNJ, Newark, NJ, USA, Department of Research, AI duPont Hospital for Children, Wilmington, DE, USA, Department of Biology, Oncology, and Genetics and Department of Health Sciences, University of Genoa, Italy, Department of Citogenetics, University of Bari, Italy and Department of Neuroscience, Sacred Heart Hospital, Allentown, NJ, USA.
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a probable immune-mediated pathogenesis.
Strong evidence supports the hypothesis that MS is determined by genetic and environmental factors, but these factors remain largely undefined.
The genetic component is suggested by a higher concordance rate in monozygotic (28%) versus dizygotic (5%) twins as well as familial recurrence risk.
Several studies have shown association of MS with the histocompatibility leukocyte antigen (HLA) class II region, specifically DR15, DQ6.
However, there is no convincing evidence of a common susceptibility locus.
We have identified a pedigree of Pennsylvania Dutch extraction, in which MS segregates with an autosomal dominant inheritance pattern.
We have collected blood samples from 18 family members, seven of whom show typical signs of MS lesions by magnetic resonance imaging.
The 18 individuals were serotyped for HLA class I and II and analyzed by a genome-wide screen for linkage analysis.
We have found evidence for suggestive linkage to markers on 12p12 with a maximum multipoint LOD score of 2.71, conditional on the presence of DR15, DQ6.
Contingency table analysis showed that all MS affected individuals have both the DR15, DQ6 allele and the 12p12 haplotype whereas the unaffected individuals have either one or neither of these markers (P = 0.00011).
Our data suggests that both HLA DR15, DQ6 and a novel locus on chromosome 12p12 may be necessary for development of MS in this family.